Erbay, B. And Blair, G. E. 2022. Novel Oncolytic Adenoviruses whose replication is driven by CDC20 promoter show selective targeting of p53-negative cancer cells. ESGCT/BSGCT Collabirative Congress , (Edinburgh, England), 23.

Erbay, B., & Blair, G. E., (2022). Novel Oncolytic Adenoviruses whose replication is driven by CDC20 promoter show selective targeting of p53-negative cancer cells . ESGCT/BSGCT Collabirative Congress (pp.23). Edinburgh, England

Erbay, Bilgi, And George Eric Blair. "Novel Oncolytic Adenoviruses whose replication is driven by CDC20 promoter show selective targeting of p53-negative cancer cells," ESGCT/BSGCT Collabirative Congress, Edinburgh, England, 2022

Erbay, Bilgi And Blair, George E. . "Novel Oncolytic Adenoviruses whose replication is driven by CDC20 promoter show selective targeting of p53-negative cancer cells." ESGCT/BSGCT Collabirative Congress , Edinburgh, England, pp.23, 2022

Erbay, B. And Blair, G. E. (2022) . "Novel Oncolytic Adenoviruses whose replication is driven by CDC20 promoter show selective targeting of p53-negative cancer cells." ESGCT/BSGCT Collabirative Congress , Edinburgh, England, p.23.

@conferencepaper{conferencepaper, author={Bilgi Erbay And author={George Eric Blair}, title={Novel Oncolytic Adenoviruses whose replication is driven by CDC20 promoter show selective targeting of p53-negative cancer cells}, congress name={ESGCT/BSGCT Collabirative Congress}, city={Edinburgh}, country={England}, year={2022}, pages={23} }